Curis
CRIS
#10209
Rank
A$21.44 M
Marketcap
A$1.57
Share price
-2.63%
Change (1 day)
-67.64%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2025 (TTM): A-$5.79

According to Curis's latest financial reports the company's current EPS (TTM) is A-$5.18. In 2024 the company made an earnings per share (EPS) of A-$9.92 an increase over its 2023 EPS that were of A-$12.74.

EPS history for Curis from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$5.79-41.67%
2024A-$9.92-22.15%
2023A-$12.74-26.17%
2022A-$17.2622.3%
2021A-$14.11-25.37%
2020A-$18.91-30.93%
2019A-$27.38-2.02%
2018A-$27.94
2016A-$63.50-10%
2015A-$70.56138.1%
2014A-$29.6440%
2013A-$21.17-25%
2012A-$28.2266.67%
2011A-$16.93

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
A$1.92-137.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$4.19-180.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
A-$0.51-90.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
A$3.36-164.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
A-$4.77-7.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
A-$15.86 206.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$1.99-138.42%๐Ÿ‡บ๐Ÿ‡ธ USA